View more job listings or post a job
Jazz Pharmaceuticals Senior Manager, Clinical Pharmacology
Nektar Therapeutics Research Associate III
Nektar Therapeutics Sr. Scientist, Bioanalytical
Genentech, Inc. Associate Scientist/Scientist, Drug Metabolism and Pharmacokinetics
Jubilant Discovery Services Senior Manager Business Development
Aimmune Therapeutics The Associate Director, Quality Control will be a key member of the analytical team and he/she will support activities associated with quality control activities of Aimmune’s APIs and drug products conducted at CTL/CMO.  
Precision for Medicine Senior Manager, Quality Assurance
Denali Therapeutics Bioanalytical Research Scientist, DMPK (SM/Biomarker)
Arena Pharmaceuticals The Principal Scientist will report to the Head of Analytical Sciences and will serve as the analytical lead in cross-functional product development tea
Genentech Associate Scientist/Scientist, Process Analytical Technology, Small Molecule Analytical Chemistry  
Post a job


Immuno-Oncology: Advances in Translating from Bench to Clinic

Speakers: Luis Borges, Deborah Charych, Ravi Majeti, Brian Wong, Juan Jaen, Tara Arvedson, Jason DeVoss, Lelia Delamarre, Cheng Liu
Organizers: Snow Ge (Nektar), Deborah Charych (Nektar), Wenfeng Xu (Genentech)
Date: 2017-06-28
Time: 8:45-17:00 Pacific Time
Registration fee (USD): Regular: $195; Academic: $125; Students & Unemployed: $35
Location: Crowne Plaza, Foster City, CA
Major Sponsor: (2)Celerion; Charles River
Vendor show vendors registered to date: (23)Applied BioMath; Aragen Bioscience, Inc.; BioLegend; Bio-Techne; Cardinal Health; Cellular Dynamics Intl; Covance; CrownBio; Cytovier LLC; Eurofins; Eurofins Pharma Discovery Services; Fujifilm Diosynth Biotechnologies; Intertek; PeproTech Inc; PharmaLegacy; PHARMout Laboratories; PPD; Premier Research; Quintara Discovery (QDI); Science Exchange; Second Genome; ThermoFisher; WuXi Apptec
Registration deadline:2017-06-27  (it will close sooner if the seating cap is reached)

About the Topic

8:45-8:55  Opening Remarks and Introduction

8:55-9:35  Discovery of new drug targets and therapeutic approaches for cancer immunotherapy (Luis Borges, SVP, Five Prime Therapeutics)

9:35-10:15  Harnessing the Potent IL2 Immune Stimulatory Pathway with Designer Polymers (Deborah Charych, ED, Nektar)

10:15-10:25  Major sponsor presentation (Charles River)

10:25-10:40  Break

10:40-11:20  Pre-Clinical Development of a Humanized Anti-CD47 Antibody (Ravi Majeti, Professor, Stanford)

11:20-12:00  Discovery and development of orally-available cancer immunotherapies (Brian Wong, CEO, FLX Bio)

12:00-1:00  Lunch

1:00-1:40  Small Molecules, Antibodies, and Cell-based Therapies in the Fight Against Cancer (Juan Jaen, Founder and President, Arcus Biosciences and PACT Pharma)

1:40-2:20  Blincyto and BiTE® Antibody Platform for Cancer Therapy (Tara Arvedson, Principal Scientist, Amgen)

2:20-2:30  Major sponsor presentation (Celerion)

2:30-2:45  Break

2:45-3:25  T-VEC and oncolytic therapy (Jason DeVoss, Sr. Scientist, Amgen)

3:25-4:05  Personalized Cancer Vaccine (Lelia Delamarre, Sr. Scientist, Genentech)

4:05-4:15  Break

4:15-4:55  After CD19: CAR-T for solid tumor (Cheng Liu, CEO, Eureka)

4:55-5:15  General Q&A

2019-11-12, Antibody Drug Discovery and Development: Hit Generation, Engineering, Cell-line Development, IND enabling studies, and Biosimilars
2019-12-10, In Vitro Diagnostics (IVD), Companion Diagnostics (CDx) and Precision Medicine
2020-01-10, All about half-life: which one should I use? (tentative title)
2020-01-21, Considerations for Successful Clinical Development: Fundamentals and Best Practices for Clinical Trial Design, Biostatistics, and Data Management
2020-02-11, Development of Drug/Device Combinations
2020-02-24, MS Courses by Dr. Jack Henion: Advanced LC-MS/MS (Day1) & Interpretation of MS/MS CID Spectra (Day2)
2020-03-16, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2020-04-10, Biopolymer-based conjugation of therapeutic proteins and antibodies for improving drug properties (tentative title)
2020-05-12, Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
2020-05-22, No More Undruggables: Unconventional Approaches for Drug Discovery and Design - prodrugs, PROTACS, fragment-based design, directed evolution and beyond
2020-06-23, Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)
┬ęPharmaceutical & BioScience Society, International; Last Modified: 10/20/2019; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS & GC-MS/MS bioanalytical quantitation services of small & large molecules in any matrix. Discovery through phase IV.
XCELERATE at Biotech Week Boston Driving the Future of the Life Science Industry. Sept. 11 at BCEC. Learn more.
UC Davis UC Davis LC/MS Confirmation Supervisor (Lab Rsch Supv 2) Apply Online: UC Davis is an AA/EOE
Origin Bioanalytical Laboratory Sacramento-based CRO for bioanalytical method development, validation, and consulting of LC-MS/MS analysis, specializing in ocular matrices
BIOTECH WEEK BOSTON - Sept. 9-12 Access over 5,000 of the most innovative scientific minds & business leaders in Boston and around the world. Learn More.
Adesis Inc. Adesis provides expertise in custom synthesis, process dev, R&D, and specialty mfg. to pharma, chemical, biomaterials, and catalysts companies
Submit a Text Ad